Panion renews SME status in EU for 2019
Panion has renewed the status as Small- and Medium-sized Enterprise (SME) in the European Medicines Agency (EMA) for one more year, until the end of 2019. The application is free for the company and gives access to an increased level of advice and assistance during development and registration of medicines for the EU market. Fee waivers and fee reductions for several procedures, e.g. scientific advice, are available for SME applicants. Panion benefitted from meeting with the Innovation Task Force in EMA in June 2018. Background: EMA is committed to fostering an environment supportive to